Literature DB >> 18403439

Attempted and completed suicides after subthalamic nucleus stimulation for Parkinson's disease.

T Soulas1, J-M Gurruchaga, S Palfi, P Cesaro, J-P Nguyen, G Fénelon.   

Abstract

A higher than expected frequency of suicide has been reported among patients undergoing subthalamic nucleus deep brain stimulation (STN DBS) for advanced Parkinson's disease (PD). We conducted a retrospective survey of 200 patients with PD who underwent STN DBS. Two patients (1%) committed suicide and four (2%) attempted suicide, despite clear motor improvements. Suicidal patients did not differ from non-suicidal patients with respect to age, disease duration or preoperative depressive and cognitive status. Suicidal behaviour was associated with postoperative depression and/or altered impulse regulation. Suicidal behaviour is a potential hazard of STN DBS, calling for careful preoperative assessment and close postoperative psychiatric and behavioural follow-up.

Entities:  

Mesh:

Year:  2008        PMID: 18403439     DOI: 10.1136/jnnp.2007.130583

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  30 in total

1.  Nonmotor outcomes in Parkinson's disease: is deep brain stimulation better than dopamine replacement therapy?

Authors:  Rupam Borgohain; Rukmini Mridula Kandadai; Afshan Jabeen; Meena A Kannikannan
Journal:  Ther Adv Neurol Disord       Date:  2012-01       Impact factor: 6.570

2.  Deep brain stimulation in Parkinson's disease.

Authors:  S J Groiss; L Wojtecki; M Südmeyer; A Schnitzler
Journal:  Ther Adv Neurol Disord       Date:  2009-11       Impact factor: 6.570

Review 3.  Effects of Subthalamic Nucleus Deep Brain Stimulation on Facial Emotion Recognition in Parkinson's Disease: A Critical Literature Review.

Authors:  S Kalampokini; E Lyros; P Lochner; K Fassbender; M M Unger
Journal:  Behav Neurol       Date:  2020-07-17       Impact factor: 3.342

4.  Attempted suicide under high dose dopaminergic therapy including apomorphine.

Authors:  Walter Struhal; Michael Guger; Stephanie Hödl; Sok-Chu Ung; Michael Bach; Gerhard Ransmayr
Journal:  Wien Klin Wochenschr       Date:  2012-07-15       Impact factor: 1.704

Review 5.  Neuropsychiatric effects of subthalamic neurostimulation in Parkinson disease.

Authors:  Jens Volkmann; Christine Daniels; Karsten Witt
Journal:  Nat Rev Neurol       Date:  2010-08-03       Impact factor: 42.937

Review 6.  Psychiatric and Cognitive Effects of Deep Brain Stimulation for Parkinson's Disease.

Authors:  Adam Nassery; Christina A Palmese; Harini Sarva; Mark Groves; Joan Miravite; Brian Harris Kopell
Journal:  Curr Neurol Neurosci Rep       Date:  2016-10       Impact factor: 5.081

7.  Deep brain stimulation for the treatment of Parkinson's disease: efficacy and safety.

Authors:  Nader Pouratian; Sandeep Thakkar; Won Kim; Jeff M Bronstein
Journal:  Degener Neurol Neuromuscul Dis       Date:  2012-09-04

Review 8.  Neuropsychiatric symptoms in Parkinson's disease.

Authors:  Dag Aarsland; Laura Marsh; Anette Schrag
Journal:  Mov Disord       Date:  2009-11-15       Impact factor: 10.338

9.  Mood stability in Parkinson disease following deep brain stimulation: a 6-month prospective follow-up study.

Authors:  Amit Chopra; Osama A Abulseoud; Shirlene Sampson; Kendall H Lee; Bryan T Klassen; Julie A Fields; Joseph Y Matsumoto; Andrea C Adams; Cynthia J Stoppel; Jennifer R Geske; Mark A Frye
Journal:  Psychosomatics       Date:  2013-12-21       Impact factor: 2.386

Review 10.  Surgical treatment of Parkinson's disease: patients, targets, devices, and approaches.

Authors:  Aparna Wagle Shukla; Michael Scott Okun
Journal:  Neurotherapeutics       Date:  2014-01       Impact factor: 7.620

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.